Guidelines that reflect current scientific knowledge so that the 
public and the environment are protected from potential hazards 
of the new gene transfer technologies. There is no scientific 
rationale for limiting oversight to one subset of genetically 
novel organisms. 
We urge the RAC to recommend to the NIH Director that the 
Guidelines be updated and expanded to encompass all organisms 
possessing the same degree of genetic novelty as organisms 
produced by recombinant DNA techniques as currently defined. 
We look forward to the RAC's consideration of this request 
at the January, 1989, meeting. Please call (797-6892) if you 
have any questions. 
Sincerely, 
Jane Rissler, Ph.D 
National Biotechnology 
Policy Center 
[470] 
Recombinant DNA Research, Volume 13 
